Amalgamated Bank Sc Pharmaceuticals Inc. Transaction History
Amalgamated Bank
- $13.6 Billion
- Q3 2025
A detailed history of Amalgamated Bank transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Amalgamated Bank holds 1,358 shares of SCPH stock, worth $7,699. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,358
Previous 1,358
-0.0%
Holding current value
$7,699
Previous $5,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SCPH
# of Institutions
100Shares Held
32.9MCall Options Held
757KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA6.06MShares$34.4 Million0.82% of portfolio
-
Rubric Capital Management LP New York, NY4.6MShares$26.1 Million0.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.18MShares$12.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.15MShares$12.2 Million0.0% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX2.13MShares$12.1 Million0.05% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $155M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...